Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	681.78	6476.32	828.41
Graham Fair Price	41.97	19.30	13.60
PEG	-71.02	0.06	-0.20
Price/Book	14.00	0.48	0.42
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-39.37	5.12	8.45
Price/Sales	125.79	5.02	2.22
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	105.13	1.00	0.49
Operating Margin	14.87	< 0.005	< 0.005
ROA	80.83	< 0.005	< 0.005
ROE	0.01	0.02	88.03
ROIC	< 0.005	< 0.005	135.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.97	34.08	-97.15
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.98	-1.58	-61.90
EPS QOQ	-0.42	0.87	109.24
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	1.87	-0.49	-73.66
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-3013.65	0.00	inf
Days Sales Outstanding (DSO)	3.62	0.00	inf
Inventory Turnover	-0.03	0.00	inf
Debt/Capitalization	0.77	0.09	-88.55
Quick Ratio	5.17	6.33	22.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.80	26.71	3.53
Cash	82.80	90.54	9.34
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	4.84	2.53	-47.72
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.12	6.33	3.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	272.38	7569.29	2678.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating